Active Pharmaceutical Ingredient (API) Market Size, Share & Trends Analysis Report By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Application, By Region, ...
U.S. Active Pharmaceutical Ingredients (APIs) Market · GlobeNewswire Inc. Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Active Pharmaceutical Ingredients (APIs) Market - Growth, Trends ...
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product (Highly Potent API, Antibody Drug Conjugate), By Synthesis, ...
SAN FRANCISCO, April 29, 2025 /PRNewswire/ -- The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5.85% ...
The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical ...
Jan 31 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world's largest generic drugs ...
It’s official: Two years and one pandemic after Sanofi unveiled plans to spin off its European drug ingredients business, EUROAPI has debuted on the Euronext exchange. Shares in the new active ...
Technological progressions to increase manufacturing capacity in API production offers higher market prospects in developed markets for specialty active pharmaceutical ingredients (API). Substantial ...
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results